Odyssean »

Catalyst Pharmaceutical Partners shares owned by Odyssean

Quarter-by-quarter ownership of Catalyst Pharmaceutical Partners (CPRX) shares owned by Odyssean from 13F filings

Historical chart of Odyssean investment in Catalyst Pharmaceutical Partners

Tip: Access up to 7 years of quarterly data

All positions including Catalyst Pharmaceutical Partners held by Odyssean consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Catalyst Pharmaceutical Partners by Odyssean

Quarter filed Position value Share count Share price at filing
2026-06-30 $603k 19k 31.43

More positions owned by Odyssean

Ultragenyx Pharmaceutical (RARE)
Kymera Therapeutics (KYMR)
Ideaya Biosciences (IDYA)
Vaxcyte (PCVX)
Affirm Hldgs Com Cl A (AFRM)
Celldex Therapeutics Com New (CLDX)
Loar Holdings Com Shs (LOAR)
Mirum Pharmaceuticals (MIRM)
Doordash Cl A (DASH)
Krystal Biotech (KRYS)
Viking Holdings Ord Shs (VIK)
Medpace Hldgs (MEDP)
Toast Cl A (TOST)
American Healthcare Reit Com Shs (AHR)
Nicolet Bankshares (NIC)

View all positions for Odyssean

Top funds holding Catalyst Pharmaceutical Partners

BlackRock
State Street Corporation
American Century Companies
Vanguard Capital Management
Deerfield Management Company
Dimensional Fund Advisors
Jpmorgan Chase & Co
Bank of America Corporation
Geode Capital Management
Morgan Stanley
Vanguard Portfolio Management
Jupiter Topco
Renaissance Technologies
Henderson Group
Robeco Investment Management

View all funds holding Catalyst Pharmaceutical Partners